The recent, abrupt shortage of critical cancer drugs highlights a broken business model in generic drugs that leaves patients in the U.S. and all over the world more vulnerable to similar shortages.
Recent shortage of cancer drugs leaves patients around the world vulnerable
0 comments:
Post a Comment